# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-18T13:58:51.129664
**Route:** Direct Google API + PDF
**Tokens:** 19358 in / 693 out
**Response SHA256:** bdb7c84a75f59ac2

---

I have reviewed the draft paper "The Elasticity of Medicaid’s Safety Net: Market Responses to Provider Fraud Exclusions" for fatal errors. Below is my assessment:

### 1. DATA-DESIGN ALIGNMENT
*   **Treatment timing vs. data coverage:** The paper uses T-MSIS data from January 2018 through December 2024 (Page 9, Section 4.1). The treatment sample is restricted to exclusions with effective dates from January 2018 through December 2024 (Page 9, Section 4.2). The design is internally consistent.
*   **Post-treatment observations:** The event study uses a window of +/- 18 months (Page 13). While some cohorts treated in late 2024 may lack a full 18-month post-period, the paper explicitly notes the use of "unbalanced event-time support" (Page 13) and accounts for this in the absorption rate analysis by dropping 3 units that lack sufficient post-data (Page 18).
*   **Cutoff Data:** For the RDD-like market share threshold (3%), Figure 2 and Table 5 confirm data exists on both sides of the cutoff.

### 2. REGRESSION SANITY
*   **Standard Errors:** Table 2 (Page 16) shows standard errors for log outcomes ranging from 0.081 to 0.330. These are typical and well within the range of $|coefficient| \times 100$.
*   **Coefficients:** All coefficients in Table 2 are $<1$ for log outcomes (e.g., $-0.026$, $0.023$, $0.199$), which is highly plausible.
*   **Impossible Values:** $R^2$ values in Table 2 range from 0.826 to 0.982. No negative standard errors or "Inf/NaN" values were found in the regression tables.

### 3. COMPLETENESS
*   **Placeholder values:** I scanned all pages and tables for "TBD", "PLACEHOLDER", "XXX", and "NA". No placeholders were found.
*   **Missing elements:** Table 2 includes Observations ($N$), Standard Errors, and clear outcome headers.
*   **Internal references:** References to Figure 1 (cascade), Figure 2 (market share), Figure 3 (event study), Figure 4 (trajectory), and Figure 6 (randomization inference) all correctly point to existing figures that match the text description.

### 4. INTERNAL CONSISTENCY
*   **Data Consistency:** The abstract cites $\beta = -0.026, SE = 0.246$. This matches the preferred specification in Table 2, Column 2 (Page 16).
*   **Sample Size:** The paper consistently cites an analysis sample of 22 treated units throughout the text and in Table 1, Table 2, and Figure 1.
*   **Timing:** The study period (2018-2024) is consistent across the data description, sample construction, and appendix.

**ADVISOR VERDICT: PASS**